Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 20.50
-0.20 (-0.97%)
At close: Jun 3, 2026
Vistin Pharma ASA Company Description
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America.
It offers metformin HCl; metformin direct compressible; and metformin premixed with lubricant magnesium stearate for use in plain metformin immediate release tablets.
The company was founded in 1969 and is based in Oslo, Norway.
Vistin Pharma ASA
| Country | Norway |
| Founded | 1969 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 77 |
| CEO | Magnus Tolleshaug |
Contact Details
Address: Østensjøveien 27 Oslo, 0661 Norway | |
| Phone | 47 35 98 42 00 |
| Website | vistin.com |
Stock Details
| Ticker Symbol | VISTN |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010734122 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Magnus Tolleshaug | Chief Executive Officer |
| Alexander Karlsen | Chief Financial Officer |
| Vegard Heggem | Chief Operating Officer |
| Lilly Margareth Myra | Vice President of Quality |
| Eivind Egeli | Director of Technical Service and Sales |